This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked TREX1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TREX1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~33.2 kDa | |
| Observed band | 68 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Skin (IHC candidate; verify WB) +4 more | |
| Negative control | Bone marrow (IHC candidate; verify WB) |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Dimerization-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The A00940 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human spleen tissue lysate (catalog A00940) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A00940 · (A) 0.5 and (B) 1 μg/mL (catalog A00940) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
TREX1 is predicted at 33.2 kDa, while an empirical band is 68 kDa; the cause of the difference is not established.
| Band at 68 kDa | Empirical TREX1 band; its identity and migration mechanism need confirmation |
| Band near 33.2 kDa | Compatible with the predicted monomer mass |
| Band near twice the monomer mass | Could reflect the annotated homodimer if it survives sample preparation |
| Several bands at different positions | Could involve isoforms 1, 2, and 3; their migration is not established |
| Predicted monomer mass | 33.2 kDa from the UniProt sequence; the empirical band is 68 kDa |
| Homodimer by similarity | Could migrate near twice the monomer mass if preserved, but its contribution to the 68 kDa band is unproven |
| Splice isoform 1 | Its mass and migration relative to the other isoforms are unspecified |
| Splice isoform 2 | Its mass and migration relative to the other isoforms are unspecified |
| Splice isoform 3 | Its mass and migration relative to the other isoforms are unspecified |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TREX1 may be underrepresented in the sampled fraction because it also localizes to the nucleus and ER membrane | Check nuclear and membrane fractions alongside whole-cell lysate |
| Band higher than expected | The annotated homodimer could persist during sample preparation; its role in the 68 kDa band is unproven | Compare denaturing conditions and confirm the band with an independent TREX1 antibody or depletion control |
| Band lower than expected | A splice isoform could differ in size, but isoform masses are unspecified | Confirm identity with a second TREX1 antibody or depletion control |
| Multiple bands | Isoforms 1, 2, and 3 are annotated, but distinct bands are not established | Compare bands using an independent TREX1 antibody or depletion control |
| Weak or no signal | Nuclear or ER membrane localization may limit recovery in the tested fraction | Check extraction and compare nuclear, membrane, and whole-cell preparations |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Skin | melanocytes | High | Protein (IHC) | HPA → |
| Testis | preleptotene spermatocytes | High | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Breast | adipocytes | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Low | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for TREX1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-TREX1 antibodies have WB images: A00940 in human spleen lysate, M00940-1 in Daudi cell lysate, and PB9748 in SMMC whole-cell lysate. These images document the stated samples; PB9748 shows a band near 33 kDa versus an expected 39 kDa.
Which to pick: For mouse or rat samples, A00940 is the only listed antibody with reported reactivity, though its WB image uses human tissue. For human samples, compare the demonstrated sample contexts: spleen (A00940), Daudi cells (M00940-1), or SMMC cells (PB9748).